nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Vincristine—muscle cancer	0.146	0.224	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.146	0.224	CbGbCtD
Oxycodone—CYP3A5—Vincristine—muscle cancer	0.109	0.168	CbGbCtD
Oxycodone—CYP3A5—Etoposide—muscle cancer	0.1	0.154	CbGbCtD
Oxycodone—CYP3A4—Vincristine—muscle cancer	0.0426	0.0655	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—muscle cancer	0.0419	0.0643	CbGbCtD
Oxycodone—CYP3A4—Etoposide—muscle cancer	0.039	0.06	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—muscle cancer	0.0266	0.0409	CbGbCtD
Oxycodone—Cough—Etoposide—muscle cancer	0.000646	0.00185	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000644	0.00184	CcSEcCtD
Oxycodone—Fatigue—Vincristine—muscle cancer	0.000643	0.00184	CcSEcCtD
Oxycodone—Convulsion—Etoposide—muscle cancer	0.000641	0.00184	CcSEcCtD
Oxycodone—Hyponatraemia—Doxorubicin—muscle cancer	0.00064	0.00183	CcSEcCtD
Oxycodone—Constipation—Vincristine—muscle cancer	0.000638	0.00183	CcSEcCtD
Oxycodone—Pain—Vincristine—muscle cancer	0.000638	0.00183	CcSEcCtD
Oxycodone—Asthma—Methotrexate—muscle cancer	0.000636	0.00182	CcSEcCtD
Oxycodone—Chest pain—Etoposide—muscle cancer	0.00063	0.0018	CcSEcCtD
Oxycodone—Migraine—Doxorubicin—muscle cancer	0.000627	0.0018	CcSEcCtD
Oxycodone—Affect lability—Doxorubicin—muscle cancer	0.000627	0.0018	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000626	0.00179	CcSEcCtD
Oxycodone—Discomfort—Etoposide—muscle cancer	0.000623	0.00178	CcSEcCtD
Oxycodone—Face oedema—Doxorubicin—muscle cancer	0.000615	0.00176	CcSEcCtD
Oxycodone—Hypersensitivity—Dactinomycin—muscle cancer	0.000615	0.00176	CcSEcCtD
Oxycodone—Gastrointestinal pain—Vincristine—muscle cancer	0.00061	0.00175	CcSEcCtD
Oxycodone—Confusional state—Etoposide—muscle cancer	0.000609	0.00174	CcSEcCtD
Oxycodone—Cardiac arrest—Doxorubicin—muscle cancer	0.000606	0.00174	CcSEcCtD
Oxycodone—Anaphylactic shock—Etoposide—muscle cancer	0.000604	0.00173	CcSEcCtD
Oxycodone—Mood swings—Doxorubicin—muscle cancer	0.000604	0.00173	CcSEcCtD
Oxycodone—Infection—Etoposide—muscle cancer	0.0006	0.00172	CcSEcCtD
Oxycodone—Asthenia—Dactinomycin—muscle cancer	0.000599	0.00171	CcSEcCtD
Oxycodone—Dysuria—Methotrexate—muscle cancer	0.000595	0.0017	CcSEcCtD
Oxycodone—Dehydration—Doxorubicin—muscle cancer	0.000593	0.0017	CcSEcCtD
Oxycodone—Tachycardia—Etoposide—muscle cancer	0.00059	0.00169	CcSEcCtD
Oxycodone—Abdominal pain—Vincristine—muscle cancer	0.00059	0.00169	CcSEcCtD
Oxycodone—Body temperature increased—Vincristine—muscle cancer	0.00059	0.00169	CcSEcCtD
Oxycodone—Skin disorder—Etoposide—muscle cancer	0.000587	0.00168	CcSEcCtD
Oxycodone—Erectile dysfunction—Methotrexate—muscle cancer	0.000586	0.00168	CcSEcCtD
Oxycodone—Dry skin—Doxorubicin—muscle cancer	0.000584	0.00167	CcSEcCtD
Oxycodone—Hyperhidrosis—Etoposide—muscle cancer	0.000584	0.00167	CcSEcCtD
Oxycodone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000582	0.00167	CcSEcCtD
Oxycodone—Abdominal pain upper—Doxorubicin—muscle cancer	0.000582	0.00167	CcSEcCtD
Oxycodone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000581	0.00166	CcSEcCtD
Oxycodone—Breast disorder—Doxorubicin—muscle cancer	0.000576	0.00165	CcSEcCtD
Oxycodone—Anorexia—Etoposide—muscle cancer	0.000576	0.00165	CcSEcCtD
Oxycodone—Diarrhoea—Dactinomycin—muscle cancer	0.000571	0.00163	CcSEcCtD
Oxycodone—Pneumonia—Methotrexate—muscle cancer	0.000571	0.00163	CcSEcCtD
Oxycodone—Nasopharyngitis—Doxorubicin—muscle cancer	0.00057	0.00163	CcSEcCtD
Oxycodone—Infestation NOS—Methotrexate—muscle cancer	0.000567	0.00162	CcSEcCtD
Oxycodone—Infestation—Methotrexate—muscle cancer	0.000567	0.00162	CcSEcCtD
Oxycodone—Drowsiness—Methotrexate—muscle cancer	0.000567	0.00162	CcSEcCtD
Oxycodone—Hypotension—Etoposide—muscle cancer	0.000564	0.00162	CcSEcCtD
Oxycodone—Gastritis—Doxorubicin—muscle cancer	0.000564	0.00161	CcSEcCtD
Oxycodone—Abdominal distension—Doxorubicin—muscle cancer	0.000555	0.00159	CcSEcCtD
Oxycodone—Stomatitis—Methotrexate—muscle cancer	0.000553	0.00158	CcSEcCtD
Oxycodone—Asthma—Doxorubicin—muscle cancer	0.000551	0.00158	CcSEcCtD
Oxycodone—Dysphagia—Doxorubicin—muscle cancer	0.000551	0.00158	CcSEcCtD
Oxycodone—Influenza—Doxorubicin—muscle cancer	0.000551	0.00158	CcSEcCtD
Oxycodone—Hypersensitivity—Vincristine—muscle cancer	0.000549	0.00157	CcSEcCtD
Oxycodone—Sweating—Methotrexate—muscle cancer	0.000544	0.00156	CcSEcCtD
Oxycodone—Paraesthesia—Etoposide—muscle cancer	0.000542	0.00155	CcSEcCtD
Oxycodone—Haematuria—Methotrexate—muscle cancer	0.000541	0.00155	CcSEcCtD
Oxycodone—Dyspnoea—Etoposide—muscle cancer	0.000539	0.00154	CcSEcCtD
Oxycodone—Somnolence—Etoposide—muscle cancer	0.000537	0.00154	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—muscle cancer	0.000537	0.00154	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—muscle cancer	0.000535	0.00153	CcSEcCtD
Oxycodone—Asthenia—Vincristine—muscle cancer	0.000535	0.00153	CcSEcCtD
Oxycodone—Vomiting—Dactinomycin—muscle cancer	0.000531	0.00152	CcSEcCtD
Oxycodone—Bronchitis—Doxorubicin—muscle cancer	0.00053	0.00152	CcSEcCtD
Oxycodone—Rash—Dactinomycin—muscle cancer	0.000526	0.00151	CcSEcCtD
Oxycodone—Decreased appetite—Etoposide—muscle cancer	0.000525	0.0015	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000522	0.00149	CcSEcCtD
Oxycodone—Fatigue—Etoposide—muscle cancer	0.000521	0.00149	CcSEcCtD
Oxycodone—Pain—Etoposide—muscle cancer	0.000517	0.00148	CcSEcCtD
Oxycodone—Constipation—Etoposide—muscle cancer	0.000517	0.00148	CcSEcCtD
Oxycodone—Dysuria—Doxorubicin—muscle cancer	0.000515	0.00147	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—muscle cancer	0.000512	0.00147	CcSEcCtD
Oxycodone—Diarrhoea—Vincristine—muscle cancer	0.00051	0.00146	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—muscle cancer	0.000509	0.00146	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—muscle cancer	0.000509	0.00146	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—muscle cancer	0.000505	0.00145	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—muscle cancer	0.000503	0.00144	CcSEcCtD
Oxycodone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000503	0.00144	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—muscle cancer	0.000499	0.00143	CcSEcCtD
Oxycodone—Weight decreased—Doxorubicin—muscle cancer	0.000498	0.00143	CcSEcCtD
Oxycodone—Feeling abnormal—Etoposide—muscle cancer	0.000498	0.00142	CcSEcCtD
Oxycodone—Hyperglycaemia—Doxorubicin—muscle cancer	0.000497	0.00142	CcSEcCtD
Oxycodone—Nausea—Dactinomycin—muscle cancer	0.000496	0.00142	CcSEcCtD
Oxycodone—Pneumonia—Doxorubicin—muscle cancer	0.000494	0.00141	CcSEcCtD
Oxycodone—Gastrointestinal pain—Etoposide—muscle cancer	0.000494	0.00141	CcSEcCtD
Oxycodone—Dizziness—Vincristine—muscle cancer	0.000493	0.00141	CcSEcCtD
Oxycodone—Infestation—Doxorubicin—muscle cancer	0.000491	0.00141	CcSEcCtD
Oxycodone—Drowsiness—Doxorubicin—muscle cancer	0.000491	0.00141	CcSEcCtD
Oxycodone—Infestation NOS—Doxorubicin—muscle cancer	0.000491	0.00141	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—muscle cancer	0.000491	0.0014	CcSEcCtD
Oxycodone—Urticaria—Etoposide—muscle cancer	0.00048	0.00137	CcSEcCtD
Oxycodone—Stomatitis—Doxorubicin—muscle cancer	0.000479	0.00137	CcSEcCtD
Oxycodone—Abdominal pain—Etoposide—muscle cancer	0.000478	0.00137	CcSEcCtD
Oxycodone—Body temperature increased—Etoposide—muscle cancer	0.000478	0.00137	CcSEcCtD
Oxycodone—Urinary tract infection—Doxorubicin—muscle cancer	0.000478	0.00137	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—muscle cancer	0.000476	0.00136	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—muscle cancer	0.000475	0.00136	CcSEcCtD
Oxycodone—Vomiting—Vincristine—muscle cancer	0.000474	0.00136	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—muscle cancer	0.000473	0.00135	CcSEcCtD
Oxycodone—Sweating—Doxorubicin—muscle cancer	0.000471	0.00135	CcSEcCtD
Oxycodone—Rash—Vincristine—muscle cancer	0.00047	0.00135	CcSEcCtD
Oxycodone—Dermatitis—Vincristine—muscle cancer	0.00047	0.00134	CcSEcCtD
Oxycodone—Haematuria—Doxorubicin—muscle cancer	0.000468	0.00134	CcSEcCtD
Oxycodone—Headache—Vincristine—muscle cancer	0.000467	0.00134	CcSEcCtD
Oxycodone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000465	0.00133	CcSEcCtD
Oxycodone—Epistaxis—Doxorubicin—muscle cancer	0.000463	0.00133	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—muscle cancer	0.000462	0.00132	CcSEcCtD
Oxycodone—Sinusitis—Doxorubicin—muscle cancer	0.000461	0.00132	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—muscle cancer	0.00046	0.00132	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—muscle cancer	0.000459	0.00131	CcSEcCtD
Oxycodone—Chills—Methotrexate—muscle cancer	0.000457	0.00131	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—muscle cancer	0.000449	0.00129	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—muscle cancer	0.000446	0.00128	CcSEcCtD
Oxycodone—Hypersensitivity—Etoposide—muscle cancer	0.000445	0.00127	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—muscle cancer	0.000443	0.00127	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—muscle cancer	0.000443	0.00127	CcSEcCtD
Oxycodone—Nausea—Vincristine—muscle cancer	0.000443	0.00127	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—muscle cancer	0.000442	0.00127	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—muscle cancer	0.000441	0.00126	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—muscle cancer	0.000441	0.00126	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000439	0.00126	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—muscle cancer	0.000438	0.00125	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000436	0.00125	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—muscle cancer	0.000434	0.00124	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—muscle cancer	0.000434	0.00124	CcSEcCtD
Oxycodone—Asthenia—Etoposide—muscle cancer	0.000433	0.00124	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000433	0.00124	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—muscle cancer	0.000432	0.00124	CcSEcCtD
Oxycodone—Back pain—Methotrexate—muscle cancer	0.000429	0.00123	CcSEcCtD
Oxycodone—Pruritus—Etoposide—muscle cancer	0.000427	0.00122	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—muscle cancer	0.000425	0.00122	CcSEcCtD
Oxycodone—Diarrhoea—Etoposide—muscle cancer	0.000413	0.00118	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—muscle cancer	0.000412	0.00118	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—muscle cancer	0.000411	0.00118	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—muscle cancer	0.000411	0.00118	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—muscle cancer	0.00041	0.00117	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—muscle cancer	0.000409	0.00117	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—muscle cancer	0.000409	0.00117	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—muscle cancer	0.0004	0.00115	CcSEcCtD
Oxycodone—Malaise—Methotrexate—muscle cancer	0.0004	0.00114	CcSEcCtD
Oxycodone—Dizziness—Etoposide—muscle cancer	0.000399	0.00114	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—muscle cancer	0.000398	0.00114	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—muscle cancer	0.000398	0.00114	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000397	0.00114	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—muscle cancer	0.000397	0.00114	CcSEcCtD
Oxycodone—Chills—Doxorubicin—muscle cancer	0.000396	0.00113	CcSEcCtD
Oxycodone—Cough—Methotrexate—muscle cancer	0.000387	0.00111	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—muscle cancer	0.000386	0.00111	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—muscle cancer	0.000384	0.0011	CcSEcCtD
Oxycodone—Vomiting—Etoposide—muscle cancer	0.000384	0.0011	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—muscle cancer	0.000384	0.0011	CcSEcCtD
Oxycodone—Rash—Etoposide—muscle cancer	0.000381	0.00109	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—muscle cancer	0.000381	0.00109	CcSEcCtD
Oxycodone—Headache—Etoposide—muscle cancer	0.000378	0.00108	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—muscle cancer	0.000378	0.00108	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—muscle cancer	0.000377	0.00108	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—muscle cancer	0.000377	0.00108	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—muscle cancer	0.000377	0.00108	CcSEcCtD
Oxycodone—Tension—Doxorubicin—muscle cancer	0.000377	0.00108	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—muscle cancer	0.000376	0.00108	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000375	0.00107	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—muscle cancer	0.000373	0.00107	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—muscle cancer	0.000373	0.00107	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—muscle cancer	0.000371	0.00106	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—muscle cancer	0.000369	0.00106	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—muscle cancer	0.000365	0.00104	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—muscle cancer	0.000362	0.00104	CcSEcCtD
Oxycodone—Infection—Methotrexate—muscle cancer	0.000359	0.00103	CcSEcCtD
Oxycodone—Nausea—Etoposide—muscle cancer	0.000359	0.00103	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000356	0.00102	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—muscle cancer	0.000355	0.00102	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—muscle cancer	0.000355	0.00102	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—muscle cancer	0.000353	0.00101	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—muscle cancer	0.000351	0.00101	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—muscle cancer	0.00035	0.001	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—muscle cancer	0.000346	0.000991	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—muscle cancer	0.000345	0.000987	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—muscle cancer	0.000345	0.000987	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—muscle cancer	0.000344	0.000985	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—muscle cancer	0.000344	0.000984	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—muscle cancer	0.000339	0.000971	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—muscle cancer	0.000338	0.000968	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—muscle cancer	0.000337	0.000966	CcSEcCtD
Oxycodone—Cough—Doxorubicin—muscle cancer	0.000335	0.000959	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—muscle cancer	0.000333	0.000952	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00033	0.000944	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—muscle cancer	0.000327	0.000937	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—muscle cancer	0.000327	0.000936	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—muscle cancer	0.000327	0.000936	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—muscle cancer	0.000327	0.000936	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—muscle cancer	0.000326	0.000932	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—muscle cancer	0.000325	0.00093	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000325	0.000929	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—muscle cancer	0.000323	0.000924	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—muscle cancer	0.000323	0.000923	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—muscle cancer	0.000322	0.000921	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—muscle cancer	0.00032	0.000915	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—muscle cancer	0.000319	0.000912	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—muscle cancer	0.000316	0.000904	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—muscle cancer	0.000315	0.0009	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—muscle cancer	0.000313	0.000897	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000313	0.000897	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000312	0.000894	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—muscle cancer	0.000312	0.000893	CcSEcCtD
Oxycodone—Infection—Doxorubicin—muscle cancer	0.000311	0.000891	CcSEcCtD
Oxycodone—Pain—Methotrexate—muscle cancer	0.000309	0.000886	CcSEcCtD
Oxycodone—Shock—Doxorubicin—muscle cancer	0.000308	0.000882	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—muscle cancer	0.000307	0.00088	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—muscle cancer	0.000306	0.000875	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—muscle cancer	0.000304	0.000871	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000303	0.000867	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—muscle cancer	0.000299	0.000855	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—muscle cancer	0.000298	0.000853	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000296	0.000847	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—muscle cancer	0.000293	0.000838	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—muscle cancer	0.000287	0.000823	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—muscle cancer	0.000286	0.000819	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—muscle cancer	0.000286	0.000819	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000285	0.000817	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—muscle cancer	0.000283	0.000811	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—muscle cancer	0.000281	0.000805	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—muscle cancer	0.000279	0.0008	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—muscle cancer	0.000279	0.000797	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—muscle cancer	0.000276	0.000789	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—muscle cancer	0.000272	0.00078	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000271	0.000774	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—muscle cancer	0.00027	0.000773	CcSEcCtD
Oxycodone—Pain—Doxorubicin—muscle cancer	0.000268	0.000767	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—muscle cancer	0.000268	0.000767	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—muscle cancer	0.000267	0.000763	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—muscle cancer	0.00026	0.000743	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—muscle cancer	0.000258	0.000739	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000256	0.000733	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—muscle cancer	0.000256	0.000733	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—muscle cancer	0.000249	0.000712	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—muscle cancer	0.000248	0.000709	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—muscle cancer	0.000248	0.000709	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—muscle cancer	0.000248	0.000709	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—muscle cancer	0.000239	0.000685	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—muscle cancer	0.000231	0.000661	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—muscle cancer	0.00023	0.000659	CcSEcCtD
Oxycodone—Rash—Methotrexate—muscle cancer	0.000228	0.000653	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—muscle cancer	0.000228	0.000652	CcSEcCtD
Oxycodone—Headache—Methotrexate—muscle cancer	0.000227	0.000649	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—muscle cancer	0.000225	0.000643	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—muscle cancer	0.000222	0.000635	CcSEcCtD
Oxycodone—Nausea—Methotrexate—muscle cancer	0.000215	0.000615	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—muscle cancer	0.000214	0.000614	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—muscle cancer	0.000207	0.000593	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—muscle cancer	0.000199	0.00057	CcSEcCtD
Oxycodone—Rash—Doxorubicin—muscle cancer	0.000198	0.000565	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—muscle cancer	0.000197	0.000565	CcSEcCtD
Oxycodone—Headache—Doxorubicin—muscle cancer	0.000196	0.000562	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—muscle cancer	0.000186	0.000533	CcSEcCtD
